Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

173 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Therapeutic drug monitoring in the treatment of tuberculosis patients.
Magis-Escurra C, van den Boogaard J, Ijdema D, Boeree M, Aarnoutse R. Magis-Escurra C, et al. Pulm Pharmacol Ther. 2012 Feb;25(1):83-6. doi: 10.1016/j.pupt.2011.12.001. Epub 2011 Dec 11. Pulm Pharmacol Ther. 2012. PMID: 22179055
Pharmacokinetics of adjusted-dose lopinavir-ritonavir combined with rifampin in healthy volunteers.
la Porte CJ, Colbers EP, Bertz R, Voncken DS, Wikstrom K, Boeree MJ, Koopmans PP, Hekster YA, Burger DM. la Porte CJ, et al. Antimicrob Agents Chemother. 2004 May;48(5):1553-60. doi: 10.1128/aac.48.5.1553-1560.2004. Antimicrob Agents Chemother. 2004. PMID: 15105105 Free PMC article. Clinical Trial.
Efficacy and safety of two dosages of cotrimoxazole as preventive treatment for HIV-infected Malawian adults with new smear-positive tuberculosis.
Boeree MJ, Sauvageot D, Banda HT, Harries AD, Zijlstra EE. Boeree MJ, et al. Trop Med Int Health. 2005 Aug;10(8):723-33. doi: 10.1111/j.1365-3156.2005.01433.x. Trop Med Int Health. 2005. PMID: 16045458 Clinical Trial.
M. tuberculosis genotypic diversity and drug susceptibility pattern in HIV-infected and non-HIV-infected patients in northern Tanzania.
Kibiki GS, Mulder B, Dolmans WM, de Beer JL, Boeree M, Sam N, van Soolingen D, Sola C, van der Zanden AG. Kibiki GS, et al. BMC Microbiol. 2007 May 31;7:51. doi: 10.1186/1471-2180-7-51. BMC Microbiol. 2007. PMID: 17540031 Free PMC article.
Determination of the prevalence of M. tuberculosis strains and their drug susceptibility is important for TB control.TB positive culture, BAL fluid or sputum samples from 130 patients were collected and genotyped. ...
Determination of the prevalence of M. tuberculosis strains and their drug susceptibility is important for TB control.TB positive cult …
Short communication: antituberculosis drug-induced hepatotoxicity is unexpectedly low in HIV-infected pulmonary tuberculosis patients in Malawi.
Tostmann A, Boeree MJ, Harries AD, Sauvageot D, Banda HT, Zijlstra EE. Tostmann A, et al. Trop Med Int Health. 2007 Jul;12(7):852-5. doi: 10.1111/j.1365-3156.2007.01871.x. Trop Med Int Health. 2007. PMID: 17596252 Clinical Trial.
Pulmonary Mycobacterium szulgai infection and treatment in a patient receiving anti-tumor necrosis factor therapy.
van Ingen J, Boeree M, Janssen M, Ullmann E, de Lange W, de Haas P, Dekhuijzen R, van Soolingen D. van Ingen J, et al. Nat Clin Pract Rheumatol. 2007 Jul;3(7):414-9. doi: 10.1038/ncprheum0538. Nat Clin Pract Rheumatol. 2007. PMID: 17599076
DIAGNOSIS: Pulmonary M. szulgai infection. MANAGEMENT: Triple drug therapy with rifampicin, ethambutol hydrochloride and clarithromycin. ...
DIAGNOSIS: Pulmonary M. szulgai infection. MANAGEMENT: Triple drug therapy with rifampicin, ethambutol hydrochloride and clarithromyc …
Antituberculosis drug-induced hepatotoxicity: concise up-to-date review.
Tostmann A, Boeree MJ, Aarnoutse RE, de Lange WC, van der Ven AJ, Dekhuijzen R. Tostmann A, et al. J Gastroenterol Hepatol. 2008 Feb;23(2):192-202. doi: 10.1111/j.1440-1746.2007.05207.x. Epub 2007 Nov 6. J Gastroenterol Hepatol. 2008. PMID: 17995946 Review.
Mycobacterium xenopi clinical relevance and determinants, the Netherlands.
van Ingen J, Boeree MJ, de Lange WC, Hoefsloot W, Bendien SA, Magis-Escurra C, Dekhuijzen R, van Soolingen D. van Ingen J, et al. Emerg Infect Dis. 2008 Mar;14(3):385-9. doi: 10.3201/eid1403.061393. Emerg Infect Dis. 2008. PMID: 18325251 Free PMC article.
To determine clinical relevance and determinants, we retrospectively reviewed medical files of all patients in the Netherlands in whom M. xenopi was isolated from January 1999 through March 2005 by using diagnostic criteria for nontuberculous mycobacterial infection publis …
To determine clinical relevance and determinants, we retrospectively reviewed medical files of all patients in the Netherlands in whom M
Isoniazid and its toxic metabolite hydrazine induce in vitro pyrazinamide toxicity.
Tostmann A, Boeree MJ, Peters WH, Roelofs HM, Aarnoutse RE, van der Ven AJ, Dekhuijzen PN. Tostmann A, et al. Int J Antimicrob Agents. 2008 Jun;31(6):577-80. doi: 10.1016/j.ijantimicag.2008.01.022. Epub 2008 Mar 21. Int J Antimicrob Agents. 2008. PMID: 18358703
173 results
Jump to page
Feedback